Strategies at the Interface of Drug Discovery and Development: Early Optimization of the Solid State Phase and Preclinical Toxicology Formulation for Potential Drug Candidates

被引:45
|
作者
Palucki, Michael [1 ]
Higgins, John D. [1 ]
Kwong, Elizabeth [1 ]
Templeton, Allen C. [1 ]
机构
[1] Merck & Co Inc, Basic Pharmaceut Sci, Merck Res Labs, West Point, PA 19486 USA
关键词
DISSOLUTION; SOLUBILITY; SELECTION; BIOAVAILABILITY; ABSORPTION; DELIVERY;
D O I
10.1021/jm1002638
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:5897 / 5905
页数:9
相关论文
共 50 条
  • [21] Synergistic Interplay of Medicinal Chemistry and Formulation Strategies in Nanotechnology - From Drug Discovery to Nanocarrier Design and Development
    Sunoqrot, Suhair
    Hamed, Rania
    Abdel-Halim, Heba
    Tarawneh, Ola
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (13) : 1451 - 1468
  • [22] Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials
    Hung, Anna
    Schneider, Monika
    Lopez, Marianne Hamilton
    McClellan, Mark
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (07): : 888 - 900
  • [23] Cycle-elimination release strategies applied to solid-phase organic synthesis in drug discovery
    Park, KH
    Kurth, MJ
    DRUGS OF THE FUTURE, 2000, 25 (12) : 1265 - 1294
  • [24] DISCOVERY AND OPTIMIZATION OF A SERIES OF BORON-CONTAINING SMALL MOLECULES AS POTENTIAL DRUG CANDIDATES FOR THE TREATMENT OF HUMAN AFRICAN TRYPANOSOMIASIS
    Orr, Matthew
    Gaukel, Eric
    Jenks, Matthew
    Nare, Bakela
    Rewerts, Cindy
    Wring, Stephen
    Ding, Charles
    Freund, Yvonne
    Plattner, Jacob
    Bacchi, Cyrus
    Yarlett, Nigel
    Don, Robert
    Jacobs, Robert
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 204 - 204
  • [25] Evaluation on the Drug–Polymer Mixing Status in Amorphous Solid Dispersions at the Early Stage Formulation and Process Development
    Hua (May) Ma
    Duk Soon Choi
    Yu-E Zhang
    Hung Tian
    Navnit Shah
    Hitesh P. Chokshi
    Journal of Pharmaceutical Innovation, 2013, 8 : 163 - 174
  • [26] Optimization of Primary Drying in Lyophilization During Early-Phase Drug Development Using a Definitive Screening Design With Formulation and Process Factors
    Goldman, Johnathan M.
    More, Haresh T.
    Yee, Olga
    Borgeson, Elizabeth
    Remy, Brenda
    Rowe, Jasmine
    Sadineni, Vikram
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (10) : 2592 - 2600
  • [27] Application of Solid-State NMR Relaxometry for Characterization and Formulation Optimization of Grinding-Induced Drug Nanoparticle
    Ueda, Keisuke
    Higashi, Kenjirou
    Moribe, Kunikazu
    MOLECULAR PHARMACEUTICS, 2016, 13 (03) : 852 - 862
  • [28] Drug Product Development of Adenovirus: Platform Approaches to Select Early Phase Formulation and Fill/Finish Strategy
    Lake, Conor R.
    Nanda, Tatiana
    Sponsel, Kayla
    Nandi, Avi
    Sacks, Amy
    Nieder, Chris
    Schutt, Kevin
    Park, Honggeun
    Hanshew, Trey
    MOLECULAR THERAPY, 2023, 31 (04) : 496 - 496
  • [29] Evaluation on the Drug-Polymer Mixing Status in Amorphous Solid Dispersions at the Early Stage Formulation and Process Development
    Ma, Hua
    Choi, Duk Soon
    Zhang, Yu-E
    Tian, Hung
    Shah, Navnit
    Chokshi, Hitesh P.
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2013, 8 (03) : 163 - 174
  • [30] Implementation of pharmacokinetic and pharrnacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research
    Tuntland, Tove
    Ethell, Brian
    Kosaka, Takatoshi
    Blasco, Francesca
    Zang, Richard Xu
    Jain, Monish
    Gould, Ty
    Hoffmaster, Keith
    FRONTIERS IN PHARMACOLOGY, 2014, 5